Author: "Kim, Tae-You" - Searchworks@Jio Institute Digital Library Search Results

Your search keyword '"Kim, Tae-You"' showing total 1,483 results

Start Over Author "Kim, Tae-You"

1,483 results on '"Kim, Tae-You"'

1. Cancer signature ensemble integrating cfDNA methylation, copy number, and fragmentation facilitates multi-cancer early detection

Author: Kim, Su Yeon, Jeong, Seongmun, Lee, Wookjae, Jeon, Yujin, Kim, Yong-Jin, Park, Seowoo, Lee, Dongin, Go, Dayoung, Song, Sang-Hyun, Lee, Sanghoo, Woo, Hyun Goo, Yoon, Jung-Ki, Park, Young Sik, Kim, Young Tae, Lee, Se-Hoon, Kim, Kwang Hyun, Lim, Yoojoo, Kim, Jin-Soo, Kim, Hwang-Phill, Bang, Duhee, and Kim, Tae-You
Published: 2023
Full Text: View/download PDF

2. Trastuzumab deruxtecan in patients with HER2-positive advanced colorectal cancer (DESTINY-CRC02): primary results from a multicentre, randomised, phase 2 trial

Author: Raghav, Kanwal, Siena, Salvatore, Takashima, Atsuo, Kato, Takeshi, Van den Eynde, Marc, Pietrantonio, Filippo, Komatsu, Yoshito, Kawakami, Hisato, Peeters, Marc, Andre, Thierry, Lonardi, Sara, Yamaguchi, Kensei, Tie, Jeanne, Castro, Cristina Gravalos, Hsu, Hung-Chih, Strickler, John H, Kim, Tae-You, Cha, Yongjun, Barrios, Daniel, Yan, Qi, Kamio, Takahiro, Kobayashi, Kojiro, Boran, Aislyn, Koga, Makito, Allard, John D, and Yoshino, Takayuki
Published: 2024
Full Text: View/download PDF

3. Personalised circulating tumour DNA assay with large-scale mutation coverage for sensitive minimal residual disease detection in colorectal cancer

Author: Ryoo, Seung-Bum, Heo, Sunghoon, Lim, Yoojoo, Lee, Wookjae, Cho, Su Han, Ahn, Jongseong, Kang, Jun-Kyu, Kim, Su Yeon, Kim, Hwang-Phill, Bang, Duhee, Kang, Sung-Bum, Yu, Chang Sik, Oh, Seong Taek, Park, Ji Won, Jeong, Seung-Yong, Kim, Young-Joon, Park, Kyu Joo, Han, Sae-Won, and Kim, Tae-You
Published: 2023
Full Text: View/download PDF

4. Four-year overall survival update from the phase III HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma

Author: Azevedo, Sergio, Braghiroli, Maria Ignez, Girotto, Gustavo, Bragagnoli, Arinilda, Branco, Ricardo, Faccio, Adilson, Moretto, Andrea, Skare, Nils, Dutra, Jamille, Viola, Luciana, Vianna, Karina, Meton, Fernando, Sette, Claudia, Faulhaber, Amanda, Tam, Vincent C., Couture, Felix, Biagi, Jim, Castel, Helene, Mulder, Karen, Ko, Yoo-Joung, Zbuk, Kevin, Welch, Stephen, Beaudoin, Annie, Heurgué, Alexandra, Assenat, Eric, Archambeaud, Isabelle, Tougeron, David, Peron, Jean-Marie, Gilabert, Marine, Bronowicki, Jean-Pierre, Cattan, Stephane, Blanc, Jean-Frederic, Bouattour, Mohamed, Phelip, Jean-Marc, Boige, Valerie, Michel, Pierre, Frin, Anne-Claire, De Toni, Enrico N., Berres, Marie-Luise, Vogel, Arndt, Berg, Thomas, Ettrich, Thomas, Waldschmidt, Dirk, Wedemeyer, Hans Heinrich, Worns, Marcus-Alexander, Bitzer, Michael, Weiss, Karl-Heinz, Lau, George, Chan, Stephen L., Yau, Thomas, Tai, Yin Ping, Lee, Ann Shing, Thungappa, Satheesh Chiradoni, N, Lokesh K., Sureshchand Ostwal, Vikas, Ashok, Kattimani Kiran, Mittal, Sushant, Goyal, Hari, Srinivasan, Sankar, Biswas, Ghanashyam, Mohan, Mallavarapu, Limaye, Sewanti, Asarawala, Nirav, Rimassa, Lorenza, Falcone, Alfredo, Gianni, Luca, Gasbarrini, Antonio, Daniele, Bruno, Avallone, Antonio, Paolo Frassineti, Giovanni Luca, Roila, Fausto, Kudo, Masatoshi, Kawaoka, Tomokazu, Morimoto, Manabu, Takikawa, Yasuhiro, Kato, Naoya, Yamashita, Tatsuya, Osaki, Yukio, Motomura, Kenta, Tateishi, Ryosuke, Ohkawa, Kazuyoshi, Wada, Yoshiyuki, Onishi, Hideki, Sasahira, Naoki, Inaba, Yoshitaka, Kurosaki, Masayuki, Tsuji, Kunihiko, Takei, Yoshiyuki, Aramaki, Takeshi, Hagihara, Atsushi, Furuse, Junji, Kioka, Kiyohide, Koga, Hironori, Sasaki, Yutaka, Numata, Kazushi, Tada, Toshifumi, Kawaguchi, Yasunori, Nadano, Seijin, Vasilyev, Alexander, Breder, Valery, Lipatov, Oleg, Dvorkin, Mikhail, Zarubenkov, Oleg, Kutukova, Svetlana, Ponomarev, Roman, Shostka, Kirill, Alyasova, Anna, Topuzov, Eldar, Severtsev, Alexey, Petrov, Yuryi, Erygin, Dmitriy, Berdov, Boris, Kang, Yoon-Koo, Tak, Won-Young, Park, Joong-Won, Lim, Ho Yeong, Heo, Jeong, Kim, Jee Hyun, Kim, Tae-You, Choi, Hye Jin, Varela, María, Reig Monzon, María Elisa, Sangro, Bruno, Martin, Carlos Gómez, Ponce, Carmen Guillén, López, Carlos, Cheng, Ann-Lii, Chao, Yee, Feng, Yin-Hsun, Jeng, Long-Bin, Hung, Chao-Hung, Hou, Ming-Mo, Wang Tsang-En Wang, Jing-Houng, Yen, Chia-Jui, Sukeepaisarnjaroen, Wattana, Sunpaweravong, Patrapim, Charoentum, Chaiyut, Tanasanvimon, Suebpong, Sirachainan, Ekaphop, Ungtrakul, Teerapat, Prasongsook, Naiyarat, Maneenil, Kunlatida, Jitpewngarm, Wittawat, Ostapenko, Yurii, Skoryi, Denys, Bondarenko, Igor, Shparyk, Yaroslav, Trukhin, Dmytro, Hotko, Yevhen, Ursol, Grygorii, Kryzhanivska, Anna, Abou-Alfa, Ghassan K., Mody, Kabir, Dayyani, Farshid, Al-Rajabi, Raed, Yarchoan, Mark, Gandhi, Sunil, Crysler, Oxana, He, Aiwu Ruth, Reeves, James, Bahary, Nathan, Mahipal, Amit, Kelley, Robin Kate, Dasgupta, Anirudha, Rowe, Julie, Thota, Ramya, Beg, Muhammad, Morse, Michael, Choi, Sung-hee, Crocenzi, Todd, Somer, Bradley, Abrams, Thomas, Denlinger, Crystal, Zhang, Yue, Sharma, Nisha, Dao, Tu V., Thinh, Nguyen Tien, Tuyet Phuong, Le Thi, Sangro, B., Chan, S.L., Kelley, R.K., Lau, G., Kudo, M., Sukeepaisarnjaroen, W., Yarchoan, M., De Toni, E.N., Furuse, J., Kang, Y.K., Galle, P.R., Rimassa, L., Heurgué, A., Tam, V.C., Van Dao, T., Thungappa, S.C., Breder, V., Ostapenko, Y., Reig, M., Makowsky, M., Paskow, M.J., Gupta, C., Kurland, J.F., Negro, A., and Abou-Alfa, G.K.
Published: 2024
Full Text: View/download PDF

5. EBS-seq: enrichment-based method for accurate analysis of 5-hydroxymethylcytosine at single-base resolution

Author: Lee, Jaywon, Lee, Dongin, Kim, Hwang-Phill, Kim, Tae-You, and Bang, Duhee
Published: 2023
Full Text: View/download PDF

6. Quantitative and qualitative mutational impact of ionizing radiation on normal cells

Author: Youk, Jeonghwan, Kwon, Hyun Woo, Lim, Joonoh, Kim, Eunji, Kim, Taewoo, Kim, Ryul, Park, Seongyeol, Yi, Kijong, Nam, Chang Hyun, Jeon, Sara, An, Yohan, Choi, Jinwook, Na, Hyelin, Lee, Eon-Seok, Cho, Youngwon, Min, Dong-Wook, Kim, HyoJin, Kang, Yeong-Rok, Choi, Si Ho, Bae, Min Ji, Lee, Chang Geun, Kim, Joon-Goon, Kim, Young Seo, Yu, Tosol, Lee, Won-Chul, Shin, Jong-Yeon, Lee, Dong Soo, Kim, Tae-You, Ku, Taeyun, Kim, Su Yeon, Lee, Joo-Hyeon, Koo, Bon-Kyoung, Lee, Hyunsook, Yi, On Vox, Han, Eon Chul, Chang, Ji Hyun, Kim, Kyung Su, Son, Tae Gen, and Ju, Young Seok
Published: 2024
Full Text: View/download PDF

7. Safety, Efficacy, and Pharmacodynamics of Tremelimumab Plus Durvalumab for Patients With Unresectable Hepatocellular Carcinoma: Randomized Expansion of a Phase I/II Study

Author: Kelley, Robin Kate, Sangro, Bruno, Harris, William, Ikeda, Masafumi, Okusaka, Takuji, Kang, Yoon-Koo, Qin, Shukui, Tai, David W-M, Lim, Ho Yeong, Yau, Thomas, Yong, Wei-Peng, Cheng, Ann-Lii, Gasbarrini, Antonio, Damian, Silvia, Bruix, Jordi, Borad, Mitesh, Bendell, Johanna, Kim, Tae-You, Standifer, Nathan, He, Philip, Makowsky, Mallory, Negro, Alejandra, Kudo, Masatoshi, and Abou-Alfa, Ghassan K
Subjects: Biomedical and Clinical Sciences, Clinical Sciences, Oncology and Carcinogenesis, HIV/AIDS, Orphan Drug, Rare Diseases, Cancer, Biotechnology, Clinical Research, Digestive Diseases, Clinical Trials and Supportive Activities, Liver Cancer, Patient Safety, Liver Disease, Evaluation of treatments and therapeutic interventions, 6.1 Pharmaceuticals, 6.2 Cellular and gene therapies, Adult, Aged, Aged, 80 and over, Antibodies, Monoclonal, Humanized, Carcinoma, Hepatocellular, Female, Humans, Liver Neoplasms, Male, Middle Aged, Oncology & Carcinogenesis, Oncology and carcinogenesis
Abstract: PurposeThis phase I/II study evaluated tremelimumab (anticytotoxic T-lymphocyte-associated antigen-4 monoclonal antibody) and durvalumab (antiprogrammed death ligand-1 monoclonal antibody) as monotherapies and in combination for patients with unresectable hepatocellular carcinoma (HCC), including a novel regimen featuring a single, priming dose of tremelimumab (ClinicalTrials.gov identifier: NCT02519348).Patients and methodsPatients with HCC who had progressed on, were intolerant to, or refused sorafenib were randomly assigned to receive T300 + D (tremelimumab 300 mg plus durvalumab 1,500 mg [one dose each during the first cycle] followed by durvalumab 1,500 mg once every 4 weeks), durvalumab monotherapy (1,500 mg once every 4 weeks), tremelimumab monotherapy (750 mg once every 4 weeks [seven doses] and then once every 12 weeks), or T75 + D (tremelimumab 75 mg once every 4 weeks plus durvalumab 1,500 mg once every 4 weeks [four doses] followed by durvalumab 1,500 mg once every 4 weeks). Safety was the primary end point. Secondary end points included objective response rate (ORR) by Response Evaluation Criteria in Solid Tumors v1.1 and overall survival; exploratory end points included circulating lymphocyte profiles.ResultsA total of 332 patients were enrolled (T300 + D, n = 75; durvalumab, n = 104; tremelimumab, n = 69; and T75 + D, n = 84). Tolerability was acceptable across arms, with grade ≥ 3 treatment-related adverse events occurring in 37.8%, 20.8%, 43.5%, and 24.4%, respectively. Confirmed ORRs (95% CI) were 24.0% (14.9 to 35.3), 10.6% (5.4 to 18.1), 7.2% (2.4 to 16.1), and 9.5% (4.2 to 17.9), respectively. An early expansion of CD8+ lymphocytes was associated with response across arms, with highest proliferating CD8+ lymphocyte levels occurring in the T300 + D arm. The median (95% CI) overall survival was 18.7 (10.8 to 27.3), 13.6 (8.7 to 17.6), 15.1 (11.3 to 20.5), and 11.3 (8.4 to 15.0) months in the T300 + D, durvalumab, tremelimumab, and T75 + D arms, respectively.ConclusionAll regimens were found to be tolerable and clinically active; however, the T300 + D regimen demonstrated the most encouraging benefit-risk profile. The unique pharmacodynamic activity and association with ORR of the T300 + D regimen further support its continued evaluation in HCC.
Published: 2021

8. Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial

Author: Strasser, Simone, Thompson, Alexander, Roohullah, Aflah, Sievert, William, Andelkovic, Vladimir, Knox, Jennifer, Davies, Janine, Asselah, Jamil, Brahmania, Mayur, Majeed, Habeeb, Villanueva, Luis, Yanez Weber, Patricio, Garrido, Marcelo, Pizarro, Gonzalo Ignacio, Yanez, Nicolas, Xu, Ruocai, Ou, Shuangyan, Ren, Zhenggang, Pan, Hongming, Meng, Zhiqiang, Gu, Kangsheng, Chen, Xi, Zhang, Tao, Hao, Chunyi, Cao, Peiguo, Guo, Yabing, Qin, Shukui, Xiao, Juxiang, Fang, Weijia, Wang, Xin, Bai, Yuxian, Chen, Xiaoming, Yan, Dong, Zhao, Hong, Ying, Jieer, Bonilla, Carlos, Urrego, Olga, Zambrano, Angela, Lema, Mauricio, Restrepo Gutierrez, Juan Carlos, Cardona, Andres, Franco Millan, Sandra, Oscar, Madiedo, Ramos, Victor, Merle, Philippe, LeSourd, Samuel, Edeline, Julien, Bronowicki, Jean-Pierre, Bourliere, Marc, Cattan, Stephane, Bouattour, Mohamed, Mineur, Laurent, Regnault, Helene, Dauvois, Barbara, Schulze, Kornelius, Folprecht, Gunnar, Geier, Andreas, Waidmann, Oliver, Finkelmeier, Fabian, Venerito, Marino, Berres, Marie-Luise, Berg, Thomas, Lange, Christian, Schmidt, Hartmut, Waldschmidt, Dirk T, Bitzer, Michael, McDermott, Ray, Duffy, Austin, Masi, Gianluca, Zagonel, Vittorina, Tonini, Giuseppe, Piscaglia, Fabio, Gori, Stefania, Rizzo, Mimma, Biscaldi, Elisa, Foltran, Luisa, Cabibbo, Giuseppe, Ikeda, Masafumi, Kudo, Masatoshi, Aikata, Hiroshi, Numata, Kazushi, Marusawa, Hiroyuki, Kato, Naoya, Kurosaki, Masayuki, Morimoto, Manabu, Yamashita, Tatsuya, Koga, Hironori, Masaki, Tsutomu, Tateishi, Ryosuke, Inaba, Yoshitaka, Arakawa, Tomohiro, Suzuki, Yoshiyuki, Akua, Norio, Kobayashi, Masahiro, Hosaka, Tetsuya, Nakamuta, Makoto, Oza, Noriko, Kondo, Shunsuke, Furuse, Junji, Nagashima, Fumio, Kitano, Masayuki, Takaguchi, Koichi, Ryoo, Baek-Yeol, Lim, Ho Yeong, Kim, Jee Hyun, Kim, Tae-You, Kim, Han Sang, Hernandez Hernandez, Carlos, Motola Kuba, Daniel, Segura Gonzalez, Manuel, Cabrera Luviano, Jesus, Huitzil Melendez, Fidel, Ramirez Godinez, Francisco, Silva-Bravo, Fernando, Gane, Edward, Stedman, Catherine, Kwiatkowski, Mariusz, Wyrwicz, Lucjan, Nowakowska-Zajdel, Ewa, Kraj, Leszek, Janczewska, Ewa, Surma-Wlodarczyk, Renata, Breder, Valeriy, Sekacheva, Marina, Orlova, Rashida, Vasilyev, Alexander, Zukov, Ruslan, Vladimirov, Vladimir, Minguez, Beatriz, Matilla Pena, Ana, Fernandez Castroagudin, Javier, Romero Gomez, Manuel, Luis Lledo, Jose, Rubin, Angel, Garcia Sanchez, Araceli, Calleja Panero, Jose, Yu, Ming-Chin, Shen, Ying-Chun, Huang, Yi-Hsiang, Jeng, Long-Bin, Chang, Ting-Tsung, Yang, Sheng-Shun, Chen, Shinn-Cherng, Dechaphunkul, Arunee, Tanwandee, Tawesak, Leerapun, Apinya, Seker, Mesut, Harputluoglu, Hakan, Cicin, Irfan, Oksuzoglu, Berna, Bilici, Mehmet, Sezgin Goksu, Sema, Artac, Mehmet, Cil, Timucin, Yalcin, Suayib, Meyer, Tim, Sarker, Debashis, Rao, Ankit, Palmer, Daniel, Evans, Jeff, Hubner, Richard, Finn, Richard, Ulahannan, Susanna, Zakari, Ahmed, Feun, Lynn, Al-Rajabi, Raed, Sung, Max, He, Aiwu, Kardosh, Adel, Goyal, Lipika, Li, Daneng, Choi, Minsig, Posada, Juan, Dodlapati, Jyothi, Shroff, Rachna, Agrawal, Saurabh, Gopaluni, Srivalli, Akce, Mehmet, Alese, Olatunji, Baron, Ari, Dunne, Richard, Loaiza-Bonilla, Arturo, Frenette, Catherine, Llovet, Josep M, Kumada, Hiromitsu, Cheng, Ann-Lii, Galle, Peter R, Kaneko, Shuichi, Wang, Anran, Mody, Kalgi, Dutcus, Corina, Dubrovsky, Leonid, Siegel, Abby B, and Finn, Richard S
Published: 2023
Full Text: View/download PDF

9. Marketing strategies for fintech companies: text data analysis of social media posts

Author: Oh, Sungwon, Park, Min Jae, Kim, Tae You, and Shin, Jiho
Published: 2023
Full Text: View/download PDF

10. Spatial and clonality-resolved 3D cancer genome alterations reveal enhancer-hijacking as a potential prognostic marker for colorectal cancer

Author: Kim, Kyukwang, Kim, Mooyoung, Lee, Andrew J., Song, Sang-Hyun, Kang, Jun-Kyu, Eom, Junghyun, Kang, Gyeong Hoon, Bae, Jeong Mo, Min, Sunwoo, Kim, Yeonsoo, Lim, Yoojoo, Kim, Han Sang, Kim, Young-Joon, Kim, Tae-You, and Jung, Inkyung
Published: 2023
Full Text: View/download PDF

11. Dynamic changes in longitudinal circulating tumour DNA profile during metastatic colorectal cancer treatment

Author: Kim, Sheehyun, Lim, Yoojoo, Kang, Jun-Kyu, Kim, Hwang-Phill, Roh, Hanseong, Kim, Su Yeon, Lee, Dongin, Bang, Duhee, Jeong, Seung-Yong, Park, Kyu Joo, Han, Sae-Won, and Kim, Tae-You
Published: 2022
Full Text: View/download PDF

12. EMT-mediated regulation of CXCL1/5 for resistance to anti-EGFR therapy in colorectal cancer

Author: Park, Ye-Lim, Kim, Hwang-Phill, Ock, Chan-Young, Min, Dong-Wook, Kang, Jun Kyu, Lim, Yoo Joo, Song, Sang-Hyun, Han, Sae-Won, and Kim, Tae-You
Published: 2022
Full Text: View/download PDF

13. Hypermethylation of PDX1, EN2, and MSX1 predicts the prognosis of colorectal cancer

Author: Lee, Yeongun, Dho, So Hee, Lee, Jiyeon, Hwang, Ji-Hyun, Kim, Minjung, Choi, Won-Young, Lee, Jin-Young, Lee, Jongwon, Chang, Woochul, Lee, Min Young, Choi, Jungmin, Kim, Tae-You, and Kim, Lark Kyun
Published: 2022
Full Text: View/download PDF

14. Hybrid-control arm construction using historical trial data for an early-phase, randomized controlled trial in metastatic colorectal cancer

Author: Li, Chen, Ferro, Ana, Mhatre, Shivani K., Lu, Danny, Lawrance, Marcus, Li, Xiao, Li, Shi, Allen, Simon, Desai, Jayesh, Fakih, Marwan, Cecchini, Michael, Pedersen, Katrina S., Kim, Tae You, Reyes-Rivera, Irmarie, Segal, Neil H., and Lenain, Christelle
Published: 2022
Full Text: View/download PDF

15. A phase 1 dose-escalation and dose-expansion study to assess the safety and efficacy of CKD-516, a novel vascular disrupting agent, in combination with Irinotecan in patients with previously treated metastatic colorectal cancer

Author: Jeong, Hyehyun, Hong, Yong Sang, Kim, Jeong Eun, Lim, Hyeong-Seok, Ahn, Joong Bae, Shin, Sang Joon, Park, Young Suk, Kim, Seung Tae, Han, Sae-Won, Kim, Tae-You, and Kim, Tae Won
Published: 2021
Full Text: View/download PDF

16. Comparison of atezolizumab plus bevacizumab and lenvatinib for hepatocellular carcinoma with portal vein tumor thrombosis

Author: Park, Jeayeon, primary, Lee, Yun Bin, additional, Ko, Yunmi, additional, Park, Youngsu, additional, Shin, Hyunjae, additional, Hur, Moon Haeng, additional, Park, Min Kyung, additional, Lee, Dae-Won, additional, Cho, Eun Ju, additional, Lee, Kyung-Hun, additional, Lee, Jeong-Hoon, additional, Yu, Su Jong, additional, Kim, Tae-Yong, additional, Kim, Yoon Jun, additional, Kim, Tae-You, additional, and Yoon, Jung-Hwan, additional
Published: 2024
Full Text: View/download PDF

17. Four-year overall survival update from the phase III HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma

Author: Sangro, B., primary, Chan, S.L., additional, Kelley, R.K., additional, Lau, G., additional, Kudo, M., additional, Sukeepaisarnjaroen, W., additional, Yarchoan, M., additional, De Toni, E.N., additional, Furuse, J., additional, Kang, Y.K., additional, Galle, P.R., additional, Rimassa, L., additional, Heurgué, A., additional, Tam, V.C., additional, Van Dao, T., additional, Thungappa, S.C., additional, Breder, V., additional, Ostapenko, Y., additional, Reig, M., additional, Makowsky, M., additional, Paskow, M.J., additional, Gupta, C., additional, Kurland, J.F., additional, Negro, A., additional, Abou-Alfa, G.K., additional, Azevedo, Sergio, additional, Braghiroli, Maria Ignez, additional, Girotto, Gustavo, additional, Bragagnoli, Arinilda, additional, Branco, Ricardo, additional, Faccio, Adilson, additional, Moretto, Andrea, additional, Skare, Nils, additional, Dutra, Jamille, additional, Viola, Luciana, additional, Vianna, Karina, additional, Meton, Fernando, additional, Sette, Claudia, additional, Faulhaber, Amanda, additional, Tam, Vincent C., additional, Couture, Felix, additional, Biagi, Jim, additional, Castel, Helene, additional, Mulder, Karen, additional, Ko, Yoo-Joung, additional, Zbuk, Kevin, additional, Welch, Stephen, additional, Beaudoin, Annie, additional, Heurgué, Alexandra, additional, Assenat, Eric, additional, Archambeaud, Isabelle, additional, Tougeron, David, additional, Peron, Jean-Marie, additional, Gilabert, Marine, additional, Bronowicki, Jean-Pierre, additional, Cattan, Stephane, additional, Blanc, Jean-Frederic, additional, Bouattour, Mohamed, additional, Phelip, Jean-Marc, additional, Boige, Valerie, additional, Michel, Pierre, additional, Frin, Anne-Claire, additional, Enrico N De Toni, Germany, additional, Berres, Marie-Luise, additional, Vogel, Arndt, additional, Berg, Thomas, additional, Ettrich, Thomas, additional, Waldschmidt, Dirk, additional, Wedemeyer, Hans Heinrich, additional, Worns, Marcus-Alexander, additional, Bitzer, Michael, additional, Weiss, Karl-Heinz, additional, Lau, George, additional, Chan, Stephen L., additional, Yau, Thomas, additional, Tai, Yin Ping, additional, Lee, Ann Shing, additional, Thungappa, Satheesh Chiradoni, additional, N, Lokesh K., additional, Ostwal, Vikas Sureshchand, additional, Ashok, Kattimani Kiran, additional, Mittal, Sushant, additional, Goyal, Hari, additional, Srinivasan, Sankar, additional, Biswas, Ghanashyam, additional, Mohan, Mallavarapu, additional, Limaye, Sewanti, additional, Asarawala, Nirav, additional, Rimassa, Lorenza, additional, Falcone, Alfredo, additional, Gianni, Luca, additional, Gasbarrini, Antonio, additional, Daniele, Bruno, additional, Avallone, Antonio, additional, Paolo Frassineti, Giovanni Luca, additional, Roila, Fausto, additional, Kudo, Masatoshi, additional, Kawaoka, Tomokazu, additional, Morimoto, Manabu, additional, Takikawa, Yasuhiro, additional, Kato, Naoya, additional, Yamashita, Tatsuya, additional, Osaki, Yukio, additional, Motomura, Kenta, additional, Tateishi, Ryosuke, additional, Ohkawa, Kazuyoshi, additional, Wada, Yoshiyuki, additional, Onishi, Hideki, additional, Sasahira, Naoki, additional, Inaba, Yoshitaka, additional, Kurosaki, Masayuki, additional, Tsuji, Kunihiko, additional, Takei, Yoshiyuki, additional, Aramaki, Takeshi, additional, Hagihara, Atsushi, additional, Furuse, Junji, additional, Kioka, Kiyohide, additional, Koga, Hironori, additional, Sasaki, Yutaka, additional, Numata, Kazushi, additional, Tada, Toshifumi, additional, Kawaguchi, Yasunori, additional, Nadano, Seijin, additional, Alexander Vasilyev, Russian Federation, additional, Breder, Valery, additional, Lipatov, Oleg, additional, Dvorkin, Mikhail, additional, Zarubenkov, Oleg, additional, Kutukova, Svetlana, additional, Ponomarev, Roman, additional, Shostka, Kirill, additional, Alyasova, Anna, additional, Topuzov, Eldar, additional, Severtsev, Alexey, additional, Petrov, Yuryi, additional, Erygin, Dmitriy, additional, Berdov, Boris, additional, Kang, Yoon-Koo, additional, Tak, Won-Young, additional, Park, Joong-Won, additional, Lim, Ho Yeong, additional, Heo, Jeong, additional, Kim, Jee Hyun, additional, Kim, Tae-You, additional, Choi, Hye Jin, additional, Varela, María, additional, Reig Monzon, María Elisa, additional, Sangro, Bruno, additional, Martin, Carlos Gómez, additional, Ponce, Carmen Guillén, additional, López, Carlos, additional, Cheng, Ann-Lii, additional, Chao, Yee, additional, Feng, Yin-Hsun, additional, Jeng, Long-Bin, additional, Hung, Chao-Hung, additional, Hou, Ming-Mo, additional, Wang Tsang-En Wang, Jing-Houng, additional, Yen, Chia-Jui, additional, Sukeepaisarnjaroen, Wattana, additional, Sunpaweravong, Patrapim, additional, Charoentum, Chaiyut, additional, Tanasanvimon, Suebpong, additional, Sirachainan, Ekaphop, additional, Ungtrakul, Teerapat, additional, Prasongsook, Naiyarat, additional, Maneenil, Kunlatida, additional, Jitpewngarm, Wittawat, additional, Ostapenko, Yurii, additional, Skoryi, Denys, additional, Bondarenko, Igor, additional, Shparyk, Yaroslav, additional, Trukhin, Dmytro, additional, Hotko, Yevhen, additional, Ursol, Grygorii, additional, Kryzhanivska, Anna, additional, Abou-Alfa, Ghassan K., additional, Mody, Kabir, additional, Dayyani, Farshid, additional, Al-Rajabi, Raed, additional, Yarchoan, Mark, additional, Gandhi, Sunil, additional, Crysler, Oxana, additional, He, Aiwu Ruth, additional, Reeves, James, additional, Bahary, Nathan, additional, Mahipal, Amit, additional, Kelley, Robin Kate, additional, Dasgupta, Anirudha, additional, Rowe, Julie, additional, Thota, Ramya, additional, Beg, Muhammad, additional, Morse, Michael, additional, Choi, Sung-hee, additional, Crocenzi, Todd, additional, Somer, Bradley, additional, Abrams, Thomas, additional, Denlinger, Crystal, additional, Zhang, Yue, additional, Sharma, Nisha, additional, Dao, Tu V., additional, Thinh, Nguyen Tien, additional, and Tuyet Phuong, Le Thi, additional
Published: 2024
Full Text: View/download PDF

18. Predicting disease recurrence in limited disease small cell lung cancer using cell-free DNA-based mutation and fragmentome analyses

Author: Park, Sehhoon, primary, Kang, Jun-Kyu, additional, Lee, Naeun, additional, Lee, Se-Hoon, additional, Kim, Hwang-Phill, additional, Kim, Su Yeon, additional, Kim, Tae-You, additional, Kim, Hyemin, additional, Jung, Hyun Ae, additional, Sun, Jong-Mu, additional, Ahn, Jin Seok, additional, Ahn, Myung-Ju, additional, and Park, Keunchil, additional
Published: 2024
Full Text: View/download PDF

19. Analytical and Clinical Validation of a Highly Sensitive NGS-Based ctDNA Assay with Real-World Concordance in NSCLC

Author: Yi, Hanbaek, primary, Youk, Jeonghwan, additional, Lim, Yoojoo, additional, Roh, Hanseong, additional, Roh, Dongsoo, additional, Kyung, Dongsoo, additional, Kim, Hwang-Phill, additional, Bang, Duhee, additional, Keam, Bhumsuk, additional, Kim, Tae-Min, additional, Kim, Miso, additional, Kim, Dong-Wan, additional, and Kim, Tae-You, additional
Published: 2024
Full Text: View/download PDF

20. Open versus laparoscopic surgery for mid or low rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): 10-year follow-up of an open-label, non-inferiority, randomised controlled trial

Author: Park, Ji Won, Kang, Sung-Bum, Hao, Jie, Lim, Seok-Byung, Choi, Hyo Seong, Kim, Duck-Woo, Chang, Hee Jin, Kim, Dae Yong, Jung, Kyung Hae, Kim, Tae-You, Kang, Gyeong Hoon, Chie, Eui Kyu, Kim, Sun Young, Sohn, Dae Kyung, Kim, Jae-Sung, Lee, Hye Seung, Kim, Jee Hyun, Jeong, Seung-Yong, and Oh, Jae Hwan
Published: 2021
Full Text: View/download PDF

21. Patient-reported outcomes with atezolizumab plus bevacizumab versus sorafenib in patients with unresectable hepatocellular carcinoma (IMbrave150): an open-label, randomised, phase 3 trial

Author: Galle, Peter R, Finn, Richard S, Qin, Shukui, Ikeda, Masafumi, Zhu, Andrew X, Kim, Tae-You, Kudo, Masatoshi, Breder, Valeriy, Merle, Philippe, Kaseb, Ahmed, Li, Daneng, Mulla, Sohail, Verret, Wendy, Xu, Derek-Zhen, Hernandez, Sairy, Ding, Beiying, Liu, Juan, Huang, Chen, Lim, Ho Yeong, Cheng, Ann-Lii, and Ducreux, Michel
Published: 2021
Full Text: View/download PDF

22. Randomised Phase 1b/2 trial of tepotinib vs sorafenib in Asian patients with advanced hepatocellular carcinoma with MET overexpression

Author: Ryoo, Baek-Yeol, Cheng, Ann-Li, Ren, Zhenggang, Kim, Tae-You, Pan, Hongming, Rau, Kun-Ming, Choi, Hye Jin, Park, Joong-Won, Kim, Jee Hyun, Yen, Chia Jui, Lim, Ho Yeong, Zhou, Dongli, Straub, Josef, Scheele, Juergen, Berghoff, Karin, and Qin, Shukui
Published: 2021
Full Text: View/download PDF

23. A Phase 1b/2a Study of GC1118 with 5-Fluorouracil, Leucovorin and Irinotecan (FOLFIRI) in Patients with Recurrent or Metastatic Colorectal Cancer.

Author: Lee, Keun-Wook, Han, Sae-Won, Kim, Tae Won, Ahn, Joong Bae, Baek, Ji Yeon, Cho, Sang Hee, Lee, Howard, Kim, Jin Won, Kim, Ji-Won, Kim, Tae-You, Hong, Yong Sang, Beom, Seung-Hoon, Cha, Yongjun, Choi, Yoonjung, Kim, Seonhui, and Bang, Yung-Jue
Subjects: ACNEIFORM eruptions, CANCER chemotherapy, IRINOTECAN, EPIDERMAL growth factor receptors, COLORECTAL cancer, METASTASIS
Abstract: Purpose GC1118 is a novel antibody targeting epidermal growth factor receptor (EGFR) with enhanced blocking activity against both low- and high-affinity EGFR ligands. A phase 1b/2a study was conducted to determine a recommended phase 2 dose (RP2D) of GC1118 in combination with 5-fluorouracil, leucovorin, and irinotecan (FOLFIRI) (phase 1b) and to assess the safety and efficacy of GC1118 plus FOLFIRI as a second-line therapy for recurrent/metastatic colorectal cancer (CRC) (phase 2a). Materials and Methods Phase 1b was designed as a standard 3+3 dose-escalation study with a starting dose of GC1118 (3 mg/kg/wk) in combination with biweekly FOLFIRI (irinotecan 180 mg/m2; leucovorin 400 mg/m2; 5-fluorouracil 400 mg/m2 bolus and 2,400 mg/m2 infusion over 46 hours) in patients with solid tumors refractory to standard treatments. The subsequent phase 2a part was conducted with objective response rate (ORR) as a primary endpoint. Patients with KRAS/NRAS/BRAF wild-type, EGFR-positive, recurrent/metastatic CRC resistant to the first-line treatment were enrolled in the phase 2a study. Results RP2D of GC1118 was determined to be 3 mg/kg/wk in the phase 1b study (n=7). Common adverse drug reactions (ADRs) observed in the phase 2a study (n=24) were acneiform rash (95.8%), dry skin (66.7%), paronychia (58.3%), and stomatitis (50.0%). The most common ADR of = grade 3 was neutropenia (33.3%). ORR was 42.5% (95% confidence interval [CI], 23.5 to 62.0), and median progression-free survival was 6.7 months (95% CI, 4.0 to 8.0). Conclusion GC1118 administered weekly at 3 mg/kg in combination with FOLFIRI appears as an effective and safe treatment option in recurrent/metastatic CRC. [ABSTRACT FROM AUTHOR]
Published: 2024
Full Text: View/download PDF

24. Development of a Nomogram to Predict the Recurrence Score of 21-Gene Prediction Assay in Hormone Receptor–Positive Early Breast Cancer

Author: Yoo, Shin Hye, Kim, Tae-Yong, Kim, Miso, Lee, Kyung-Hun, Lee, Eunshin, Lee, Han-Byoel, Moon, Hyeong-Gon, Han, Wonshik, Noh, Dong-Young, Han, Sae-Won, Kim, Tae-You, and Im, Seock-Ah
Published: 2020
Full Text: View/download PDF

25. A Phase 1b/2a Study of GC1118 with 5-Fluorouracil, Leucovorin and Irinotecan (FOLFIRI) in Patients with Recurrent or Metastatic Colorectal Cancer

Author: Lee, Keun-Wook, primary, Han, Sae-Won, additional, Kim, Tae Won, additional, Ahn, Joong Bae, additional, Baek, Ji Yeon, additional, Cho, Sang Hee, additional, Lee, Howard, additional, Kim, Jin Won, additional, Kim, Ji-Won, additional, Kim, Tae-You, additional, Hong, Yong Sang, additional, Beom, Seung-Hoon, additional, Cha, Yongjun, additional, Choi, Yoonjung, additional, Kim, Seonhui, additional, and Bang, Yung-Jue, additional
Published: 2023
Full Text: View/download PDF

26. Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial

Author: Llovet, Josep M, primary, Kudo, Masatoshi, additional, Merle, Philippe, additional, Meyer, Tim, additional, Qin, Shukui, additional, Ikeda, Masafumi, additional, Xu, Ruocai, additional, Edeline, Julien, additional, Ryoo, Baek-Yeol, additional, Ren, Zhenggang, additional, Masi, Gianluca, additional, Kwiatkowski, Mariusz, additional, Lim, Ho Yeong, additional, Kim, Jee Hyun, additional, Breder, Valeriy, additional, Kumada, Hiromitsu, additional, Cheng, Ann-Lii, additional, Galle, Peter R, additional, Kaneko, Shuichi, additional, Wang, Anran, additional, Mody, Kalgi, additional, Dutcus, Corina, additional, Dubrovsky, Leonid, additional, Siegel, Abby B, additional, Finn, Richard S, additional, Strasser, Simone, additional, Thompson, Alexander, additional, Roohullah, Aflah, additional, Sievert, William, additional, Andelkovic, Vladimir, additional, Knox, Jennifer, additional, Davies, Janine, additional, Asselah, Jamil, additional, Brahmania, Mayur, additional, Majeed, Habeeb, additional, Villanueva, Luis, additional, Yanez Weber, Patricio, additional, Garrido, Marcelo, additional, Pizarro, Gonzalo Ignacio, additional, Yanez, Nicolas, additional, Ou, Shuangyan, additional, Pan, Hongming, additional, Meng, Zhiqiang, additional, Gu, Kangsheng, additional, Chen, Xi, additional, Zhang, Tao, additional, Hao, Chunyi, additional, Cao, Peiguo, additional, Guo, Yabing, additional, Xiao, Juxiang, additional, Fang, Weijia, additional, Wang, Xin, additional, Bai, Yuxian, additional, Chen, Xiaoming, additional, Yan, Dong, additional, Zhao, Hong, additional, Ying, Jieer, additional, Bonilla, Carlos, additional, Urrego, Olga, additional, Zambrano, Angela, additional, Lema, Mauricio, additional, Restrepo Gutierrez, Juan Carlos, additional, Cardona, Andres, additional, Franco Millan, Sandra, additional, Oscar, Madiedo, additional, Ramos, Victor, additional, LeSourd, Samuel, additional, Bronowicki, Jean-Pierre, additional, Bourliere, Marc, additional, Cattan, Stephane, additional, Bouattour, Mohamed, additional, Mineur, Laurent, additional, Regnault, Helene, additional, Dauvois, Barbara, additional, Schulze, Kornelius, additional, Folprecht, Gunnar, additional, Geier, Andreas, additional, Waidmann, Oliver, additional, Finkelmeier, Fabian, additional, Venerito, Marino, additional, Berres, Marie-Luise, additional, Berg, Thomas, additional, Lange, Christian, additional, Schmidt, Hartmut, additional, Waldschmidt, Dirk T, additional, Bitzer, Michael, additional, McDermott, Ray, additional, Duffy, Austin, additional, Zagonel, Vittorina, additional, Tonini, Giuseppe, additional, Piscaglia, Fabio, additional, Gori, Stefania, additional, Rizzo, Mimma, additional, Biscaldi, Elisa, additional, Foltran, Luisa, additional, Cabibbo, Giuseppe, additional, Aikata, Hiroshi, additional, Numata, Kazushi, additional, Marusawa, Hiroyuki, additional, Kato, Naoya, additional, Kurosaki, Masayuki, additional, Morimoto, Manabu, additional, Yamashita, Tatsuya, additional, Koga, Hironori, additional, Masaki, Tsutomu, additional, Tateishi, Ryosuke, additional, Inaba, Yoshitaka, additional, Arakawa, Tomohiro, additional, Suzuki, Yoshiyuki, additional, Akua, Norio, additional, Kobayashi, Masahiro, additional, Hosaka, Tetsuya, additional, Nakamuta, Makoto, additional, Oza, Noriko, additional, Kondo, Shunsuke, additional, Furuse, Junji, additional, Nagashima, Fumio, additional, Kitano, Masayuki, additional, Takaguchi, Koichi, additional, Kim, Tae-You, additional, Kim, Han Sang, additional, Hernandez Hernandez, Carlos, additional, Motola Kuba, Daniel, additional, Segura Gonzalez, Manuel, additional, Cabrera Luviano, Jesus, additional, Huitzil Melendez, Fidel, additional, Ramirez Godinez, Francisco, additional, Silva-Bravo, Fernando, additional, Gane, Edward, additional, Stedman, Catherine, additional, Wyrwicz, Lucjan, additional, Nowakowska-Zajdel, Ewa, additional, Kraj, Leszek, additional, Janczewska, Ewa, additional, Surma-Wlodarczyk, Renata, additional, Sekacheva, Marina, additional, Orlova, Rashida, additional, Vasilyev, Alexander, additional, Zukov, Ruslan, additional, Vladimirov, Vladimir, additional, Minguez, Beatriz, additional, Matilla Pena, Ana, additional, Fernandez Castroagudin, Javier, additional, Romero Gomez, Manuel, additional, Luis Lledo, Jose, additional, Rubin, Angel, additional, Garcia Sanchez, Araceli, additional, Calleja Panero, Jose, additional, Yu, Ming-Chin, additional, Shen, Ying-Chun, additional, Huang, Yi-Hsiang, additional, Jeng, Long-Bin, additional, Chang, Ting-Tsung, additional, Yang, Sheng-Shun, additional, Chen, Shinn-Cherng, additional, Dechaphunkul, Arunee, additional, Tanwandee, Tawesak, additional, Leerapun, Apinya, additional, Seker, Mesut, additional, Harputluoglu, Hakan, additional, Cicin, Irfan, additional, Oksuzoglu, Berna, additional, Bilici, Mehmet, additional, Sezgin Goksu, Sema, additional, Artac, Mehmet, additional, Cil, Timucin, additional, Yalcin, Suayib, additional, Sarker, Debashis, additional, Rao, Ankit, additional, Palmer, Daniel, additional, Evans, Jeff, additional, Hubner, Richard, additional, Finn, Richard, additional, Ulahannan, Susanna, additional, Zakari, Ahmed, additional, Feun, Lynn, additional, Al-Rajabi, Raed, additional, Sung, Max, additional, He, Aiwu, additional, Kardosh, Adel, additional, Goyal, Lipika, additional, Li, Daneng, additional, Choi, Minsig, additional, Posada, Juan, additional, Dodlapati, Jyothi, additional, Shroff, Rachna, additional, Agrawal, Saurabh, additional, Gopaluni, Srivalli, additional, Akce, Mehmet, additional, Alese, Olatunji, additional, Baron, Ari, additional, Dunne, Richard, additional, Loaiza-Bonilla, Arturo, additional, and Frenette, Catherine, additional
Published: 2023
Full Text: View/download PDF

27. Microenvironment of Adjacent Non-Neoplastic Regions Determines Prognostic Outcomes in Locally Advanced Colorectal Cancer after Surgical Resection: A Multi-Center & Multi-Omics study

Author: Park, Woong-Yang, primary, Bang, Yeong Hak, additional, Choi, Ji Hye, additional, Park, Kyunghee, additional, Lim, Jinyeong, additional, Lee, Boram, additional, Han, Kyung Yeon, additional, Pyo, Dae Hee, additional, Cho, Yong Beom, additional, Kim, Tae-You, additional, Park, Kyu Joo, additional, Ryoo, Seung-Bum, additional, Kang, Sung-Bum, additional, Yu, Chang Sik, additional, Lee, Jaeim, additional, Lee, Kil-yong, additional, Kim, Kyu-Tae, additional, Lee, Jin-Young, additional, and Kim, Young-Joon, additional
Published: 2023
Full Text: View/download PDF

28. Clinicopathological and molecular features of genome-stable colorectal cancers

Author: Jin, Lingyan, primary, Jin, Hye-Yeong, additional, Kim, Younghoon, additional, Cho, Nam-Yun, additional, Bae, Jeong-Mo, additional, KIm, Jung Ho, additional, Han, Sae_Won, additional, Kim, Tae-You, additional, and Kang, Gyeong Hoon, additional
Published: 2023
Full Text: View/download PDF

29. Tumor microenvironment-adjusted prognostic implications of the KRAS mutation subtype in patients with stage III colorectal cancer treated with adjuvant FOLFOX

Author: Park, Hye Eun, Yoo, Seung-Yeon, Cho, Nam-Yun, Bae, Jeong Mo, Han, Sae-Won, Lee, Hye Seung, Park, Kyu Joo, Kim, Tae-You, and Kang, Gyeong Hoon
Published: 2021
Full Text: View/download PDF

30. Circulating tumor DNA sequencing in colorectal cancer patients treated with first-line chemotherapy with anti-EGFR

Author: Lim, Yoojoo, Kim, Sheehyun, Kang, Jun-Kyu, Kim, Hwang-Phill, Jang, Hoon, Han, Hyojun, Kim, Hyoki, Kim, Min Jung, Lee, Kyung-Hun, Ryoo, Seung-Bum, Park, Ji Won, Jeong, Seung-Yong, Park, Kyu Joo, Kang, Gyeong Hoon, Han, Sae-Won, and Kim, Tae-You
Published: 2021
Full Text: View/download PDF

31. Lineage-dependent gene expression programs influence the immune landscape of colorectal cancer

Author: Lee, Hae-Ock, Hong, Yourae, Etlioglu, Hakki Emre, Cho, Yong Beom, Pomella, Valentina, Van den Bosch, Ben, Vanhecke, Jasper, Verbandt, Sara, Hong, Hyekyung, Min, Jae-Woong, Kim, Nayoung, Eum, Hye Hyeon, Qian, Junbin, Boeckx, Bram, Lambrechts, Diether, Tsantoulis, Petros, De Hertogh, Gert, Chung, Woosung, Lee, Taeseob, An, Minae, Shin, Hyun-Tae, Joung, Je-Gun, Jung, Min-Hyeok, Ko, Gunhwan, Wirapati, Pratyaksha, Kim, Seok Hyung, Kim, Hee Cheol, Yun, Seong Hyeon, Tan, Iain Bee Huat, Ranjan, Bobby, Lee, Woo Yong, Kim, Tae-You, Choi, Jung Kyoon, Kim, Young-Joon, Prabhakar, Shyam, Tejpar, Sabine, and Park, Woong-Yang
Published: 2020
Full Text: View/download PDF

32. Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours

Author: Hong, David S., Kang, Yoon-Koo, Borad, Mitesh, Sachdev, Jasgit, Ejadi, Samuel, Lim, Ho Yeong, Brenner, Andrew J., Park, Keunchil, Lee, Jae-Lyun, Kim, Tae-You, Shin, Sangjoon, Becerra, Carlos R., Falchook, Gerald, Stoudemire, Jay, Martin, Desiree, Kelnar, Kevin, Peltier, Heidi, Bonato, Vinicius, Bader, Andreas G., Smith, Susan, Kim, Sinil, O’Neill, Vincent, and Beg, Muhammad S.
Published: 2020
Full Text: View/download PDF

33. Nivolumab in advanced hepatocellular carcinoma: Sorafenib-experienced Asian cohort analysis

Author: Yau, Thomas, Hsu, Chiun, Kim, Tae-You, Choo, Su-Pin, Kang, Yoon-Koo, Hou, Ming-Mo, Numata, Kazushi, Yeo, Winnie, Chopra, Akhil, Ikeda, Masafumi, Kuromatsu, Ryoko, Moriguchi, Michihisa, Chao, Yee, Zhao, Huanyu, Anderson, Jeffrey, Cruz, Christine Dela, and Kudo, Masatoshi
Published: 2019
Full Text: View/download PDF

34. Epigenetic insights into colorectal cancer: comprehensive genome-wide DNA methylation profiling of 294 patients in Korea

Author: Joe, Soobok, primary, Kim, Jinyong, additional, Lee, Jin-Young, additional, Jeon, Jongbum, additional, Byeon, Iksu, additional, Han, Sae-Won, additional, Ryoo, Seung-Bum, additional, Park, Kyu Joo, additional, Song, Sang-Hyun, additional, Cho, Sheehyun, additional, Shim, Hyeran, additional, Chu, Hoang Bao Khanh, additional, Kang, Jisun, additional, Lee, Hong Seok, additional, Kim, DongWoo, additional, Kim, Young-Joon, additional, Kim, Tae-You, additional, and Kim, Seon-Young, additional
Published: 2023
Full Text: View/download PDF

35. Circulating Tumor DNA Dynamics and Treatment Outcome of Regorafenib in Metastatic Colorectal Cancer

Author: Lee, Dae-Won, primary, Lim, Yoojoo, additional, Kim, Hwang-Phill, additional, Kim, Su Yeon, additional, Roh, Hanseong, additional, Kang, Jun-Kyu, additional, Lee, Kyung‑Hun, additional, Kim, Min Jung, additional, Ryoo, Seung-Bum, additional, Park, Ji Won, additional, Jeong, Seung-Yong, additional, Park, Kyu Joo, additional, Kang, Gyeong Hoon, additional, Han, Sae-Won, additional, and Kim, Tae-You, additional
Published: 2023
Full Text: View/download PDF

36. Novel graded prognostic assessment for colorectal cancer patients with brain metastases

Author: Kim, Byoung Hyuck, Park, Hae Jin, Kim, Kyubo, Han, Sae-Won, Kim, Tae-You, Jeong, Seung-Yong, Park, Kyu Joo, and Chie, Eui Kyu
Published: 2018
Full Text: View/download PDF

37. Phase I/II study of first-line combination therapy with sorafenib plus resminostat, an oral HDAC inhibitor, versus sorafenib monotherapy for advanced hepatocellular carcinoma in east Asian patients

Author: Tak, Won Young, Ryoo, Baek-Yeol, Lim, Ho Yeong, Kim, Do-Young, Okusaka, Takuji, Ikeda, Masafumi, Hidaka, Hisashi, Yeon, Jong-Eun, Mizukoshi, Eishiro, Morimoto, Manabu, Lee, Myung-Ah, Yasui, Kohichiroh, Kawaguchi, Yasunori, Heo, Jeong, Morita, Sojiro, Kim, Tae-You, Furuse, Junji, Katayama, Kazuhiro, Aramaki, Takeshi, Hara, Rina, Kimura, Takuya, Nakamura, Osamu, and Kudo, Masatoshi
Published: 2018
Full Text: View/download PDF

38. Association Between Fusobacterium nucleatum, Pathway Mutation, and Patient Prognosis in Colorectal Cancer

Author: Lee, Dae-Won, Han, Sae-Won, Kang, Jun-Kyu, Bae, Jeong Mo, Kim, Hwang-Phill, Won, Jae-Kyung, Jeong, Seung-Yong, Park, Kyu Joo, Kang, Gyeong Hoon, and Kim, Tae-You
Published: 2018
Full Text: View/download PDF

39. Body mass index and body weight change during adjuvant chemotherapy in colon cancer patients: results from the AVANT trial

Author: Lee, Dae-Won, Cho, Sooyoung, Shin, Aesun, Han, Sae-Won, and Kim, Tae-You
Published: 2020
Full Text: View/download PDF

40. Chemoradiation-Induced Alteration of Programmed Death-Ligand 1 and CD8+ Tumor-Infiltrating Lymphocytes Identified Patients With Poor Prognosis in Rectal Cancer: A Matched Comparison Analysis

Author: Lim, Yu Jin, Koh, Jaemoon, Kim, Sehui, Jeon, Sang-Rok, Chie, Eui Kyu, Kim, Kyubo, Kang, Gyeong Hoon, Han, Sae-Won, Kim, Tae-You, Jeong, Seung-Yong, Park, Kyu Joo, and Wu, Hong-Gyun
Published: 2017
Full Text: View/download PDF

41. Practical Utility of Liquid Biopsies for Evaluating Genomic Alterations in Castration-Resistant Prostate Cancer

Author: Jeong, Seung-Hwan, primary, Kyung, Dongsoo, additional, Yuk, Hyeong Dong, additional, Jeong, Chang Wook, additional, Lee, Wookjae, additional, Yoon, Jung-Ki, additional, Kim, Hwang-Phill, additional, Bang, Duhee, additional, Kim, Tae-You, additional, Lim, Yoojoo, additional, and Kwak, Cheol, additional
Published: 2023
Full Text: View/download PDF

42. Mutational evolution after chemotherapy‐progression in metastatic colorectal cancer revealed by circulating tumor DNA analysis

Author: Kim, Sheehyun, primary, Cha, Yongjun, additional, Lim, Yoojoo, additional, Roh, Hanseong, additional, Kang, Jun‐Kyu, additional, Lee, Kyung‐Hun, additional, Kim, Min Jung, additional, Park, Ji Won, additional, Ryoo, Seung‐Bum, additional, Kim, Hwang‐Phill, additional, Jeong, Seung‐Yong, additional, Park, Kyu Joo, additional, Han, Sae‐Won, additional, and Kim, Tae‐You, additional
Published: 2023
Full Text: View/download PDF

43. Supplementary Figure 2 from Antitumor Activity of Saracatinib (AZD0530), a c-Src/Abl Kinase Inhibitor, Alone or in Combination with Chemotherapeutic Agents in Gastric Cancer

Author: Nam, Hyun-Jin, primary, Im, Seock-Ah, primary, Oh, Do-Youn, primary, Elvin, Paul, primary, Kim, Hwang-Phill, primary, Yoon, Young-Kwang, primary, Min, Ahrum, primary, Song, Sang-Hyun, primary, Han, Sae-Won, primary, Kim, Tae-You, primary, and Bang, Yung-Jue, primary
Published: 2023
Full Text: View/download PDF

44. Supplementary Figure 1 from Antitumor Activity of Saracatinib (AZD0530), a c-Src/Abl Kinase Inhibitor, Alone or in Combination with Chemotherapeutic Agents in Gastric Cancer

Author: Nam, Hyun-Jin, primary, Im, Seock-Ah, primary, Oh, Do-Youn, primary, Elvin, Paul, primary, Kim, Hwang-Phill, primary, Yoon, Young-Kwang, primary, Min, Ahrum, primary, Song, Sang-Hyun, primary, Han, Sae-Won, primary, Kim, Tae-You, primary, and Bang, Yung-Jue, primary
Published: 2023
Full Text: View/download PDF

45. Supplementary Figures 1 - 9, Tables 1 - 2 from RAD51C-Deficient Cancer Cells Are Highly Sensitive to the PARP Inhibitor Olaparib

Author: Min, Ahrum, primary, Im, Seock-Ah, primary, Yoon, Young-Kwang, primary, Song, Sang-Hyun, primary, Nam, Hyun-Jin, primary, Hur, Hyung-Seok, primary, Kim, Hwang-Phill, primary, Lee, Kyung-Hun, primary, Han, Sae-Won, primary, Oh, Do-Youn, primary, Kim, Tae-You, primary, O'Connor, Mark J., primary, Kim, Woo-Ho, primary, and Bang, Yung-Jue, primary
Published: 2023
Full Text: View/download PDF

46. Data from Src as a Therapeutic Target in Biliary Tract Cancer

Author: Nam, Ah-Rong, primary, Kim, Ji-Won, primary, Park, Ji Eun, primary, Bang, Ju-Hee, primary, Jin, Mei Hua, primary, Lee, Kyung-Hun, primary, Kim, Tae-Yong, primary, Han, Sae-Won, primary, Im, Seock-Ah, primary, Kim, Tae-You, primary, Oh, Do-Youn, primary, and Bang, Yung-Jue, primary
Published: 2023
Full Text: View/download PDF

47. Data from RAD51C-Deficient Cancer Cells Are Highly Sensitive to the PARP Inhibitor Olaparib

Author: Min, Ahrum, primary, Im, Seock-Ah, primary, Yoon, Young-Kwang, primary, Song, Sang-Hyun, primary, Nam, Hyun-Jin, primary, Hur, Hyung-Seok, primary, Kim, Hwang-Phill, primary, Lee, Kyung-Hun, primary, Han, Sae-Won, primary, Oh, Do-Youn, primary, Kim, Tae-You, primary, O'Connor, Mark J., primary, Kim, Woo-Ho, primary, and Bang, Yung-Jue, primary
Published: 2023
Full Text: View/download PDF

48. Supplementary Figure 3 from Antitumor Activity of Saracatinib (AZD0530), a c-Src/Abl Kinase Inhibitor, Alone or in Combination with Chemotherapeutic Agents in Gastric Cancer

Author: Nam, Hyun-Jin, primary, Im, Seock-Ah, primary, Oh, Do-Youn, primary, Elvin, Paul, primary, Kim, Hwang-Phill, primary, Yoon, Young-Kwang, primary, Min, Ahrum, primary, Song, Sang-Hyun, primary, Han, Sae-Won, primary, Kim, Tae-You, primary, and Bang, Yung-Jue, primary
Published: 2023
Full Text: View/download PDF

49. Data from Antitumor Activity of Saracatinib (AZD0530), a c-Src/Abl Kinase Inhibitor, Alone or in Combination with Chemotherapeutic Agents in Gastric Cancer

Author: Nam, Hyun-Jin, primary, Im, Seock-Ah, primary, Oh, Do-Youn, primary, Elvin, Paul, primary, Kim, Hwang-Phill, primary, Yoon, Young-Kwang, primary, Min, Ahrum, primary, Song, Sang-Hyun, primary, Han, Sae-Won, primary, Kim, Tae-You, primary, and Bang, Yung-Jue, primary
Published: 2023
Full Text: View/download PDF

50. Supplementary Figure 4 from Antitumor Activity of Saracatinib (AZD0530), a c-Src/Abl Kinase Inhibitor, Alone or in Combination with Chemotherapeutic Agents in Gastric Cancer

Author: Nam, Hyun-Jin, primary, Im, Seock-Ah, primary, Oh, Do-Youn, primary, Elvin, Paul, primary, Kim, Hwang-Phill, primary, Yoon, Young-Kwang, primary, Min, Ahrum, primary, Song, Sang-Hyun, primary, Han, Sae-Won, primary, Kim, Tae-You, primary, and Bang, Yung-Jue, primary
Published: 2023
Full Text: View/download PDF

Catalog

Books, media, physical & digital resources

See catalog results

Searchworks

Select search scope, currently: Articles Catalog books, media & more in Jio Institute collections Articles journal articles & other e-resources

Search

Search Constraints

Refine your results

Search Limiters

Topic

Publication Year Range

Language

Publication Type

Journal

Region

Database

Publisher

1,483 results on '"Kim, Tae-You"'

Search Results

Catalog

Select search scope, currently: Articles

Catalog

books, media & more in Jio Institute collections

Articles

journal articles & other e-resources